370 related articles for article (PubMed ID: 19407487)
1. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
Yu SY; Chan DW; Liu VW; Ngan HY
Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
[TBL] [Abstract][Full Text] [Related]
2. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
3. Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.
Nafz J; De-Castro Arce J; Fleig V; Patzelt A; Mazurek S; Rösl F
Biochem J; 2007 May; 403(3):501-10. PubMed ID: 17212587
[TBL] [Abstract][Full Text] [Related]
4. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
5. AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner.
Sun Y; Connors KE; Yang DQ
Mol Cell Biochem; 2007 Dec; 306(1-2):239-45. PubMed ID: 17786544
[TBL] [Abstract][Full Text] [Related]
6. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
7. eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.
Thors B; Halldórsson H; Thorgeirsson G
Biochim Biophys Acta; 2011 Feb; 1813(2):322-31. PubMed ID: 21145922
[TBL] [Abstract][Full Text] [Related]
8. Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.
Xiao X; He Q; Lu C; Werle KD; Zhao RX; Chen J; Davis BC; Cui R; Liang J; Xu ZX
Gynecol Oncol; 2012 Oct; 127(1):249-55. PubMed ID: 22735790
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
Rattan R; Giri S; Singh AK; Singh I
J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
[TBL] [Abstract][Full Text] [Related]
12. Regulation of AMP-activated protein kinase by LKB1 and CaMKK in adipocytes.
Gormand A; Henriksson E; Ström K; Jensen TE; Sakamoto K; Göransson O
J Cell Biochem; 2011 May; 112(5):1364-75. PubMed ID: 21312243
[TBL] [Abstract][Full Text] [Related]
13. LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology.
Green AS; Chapuis N; Lacombe C; Mayeux P; Bouscary D; Tamburini J
Cell Cycle; 2011 Jul; 10(13):2115-20. PubMed ID: 21572254
[TBL] [Abstract][Full Text] [Related]
14. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
[TBL] [Abstract][Full Text] [Related]
15. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
Zajkowicz A; Rusin M
Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells.
Deshmukh RR; Dou QP
Breast Cancer Res Treat; 2015 Aug; 153(1):79-88. PubMed ID: 26227473
[TBL] [Abstract][Full Text] [Related]
17. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase.
Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M
Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X
Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548
[TBL] [Abstract][Full Text] [Related]
19. The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.
Kim WG; Choi HJ; Kim TY; Shong YK; Kim WB
Korean J Intern Med; 2014 Jul; 29(4):474-81. PubMed ID: 25045295
[TBL] [Abstract][Full Text] [Related]
20. 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.
Shin DJ; Kim JE; Lim TG; Jeong EH; Park G; Kang NJ; Park JS; Yeom MH; Oh DK; Bode AM; Dong Z; Lee HJ; Lee KW
J Cell Biochem; 2014 Oct; 115(10):1702-11. PubMed ID: 24821673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
